SAA-only HDL formed during the acute phase response in apoA-I(+/+) and apoA-I(-/-) mice

Journal of Lipid Research

Volumn 40, Issue 6, 1999, Pages 1090-1103

  Cabana, Veneracion G ^a   Reardon, Catherine A ^a   Wei, Bo ^a   Lukens, John R ^a   Getz, Godfrey S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Acute phase response; ApoA I; ApoA I gene knockout mice; Cholesterol; HDL; Lipopolysaccharide; Lipoprotein; Mouse plasma lipids; SAA; SAA only HDL

Indexed keywords

APOLIPOPROTEIN A; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPOLYSACCHARIDE; LIPOPROTEIN;

AMYLOIDOSIS; ANIMAL CELL; ARTICLE; ATHEROGENESIS; IMMUNOPRECIPITATION; KNOCKOUT MOUSE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACUTE-PHASE REACTION; ANIMALS; APOLIPOPROTEIN A-I; CHOLESTEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; IMMUNOSORBENT TECHNIQUES; LIPOPOLYSACCHARIDES; LIPOPROTEINS, HDL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PARTICLE SIZE; PHOSPHOLIPIDS; SERUM AMYLOID A PROTEIN; TRIGLYCERIDES;

EID: 0033062562     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Akgun, S., N. H. Ertel, A. Mosenthal, and W. Osser. 1998. Postsurgical reduction of serum lipoproteins: interleukin-6 and the acute phase response. J. Lab. Clin. Med. 131: 103-108.
2. Kumon, Y., Y. Nakauchi, K. Kidawara, M. Fukushima, S. Kobayashi, Y. Ikeda, T. Suehiro, K. Hashimoto, and J. D. Sipe. 1998. A longitudinal analysis of alteration in lecithin-cholesterol acyltransferase and paraoxonase activities following laparoscopic cholecystectomy relative to other parameters of HDL function and the acute phase response. Scand. J. Immunol. 48: 419-424.
3. Alvarez, C., and A. Ramos. 1986. Lipids, lipoproteins and apoproteins in serum during infection. Clin. Chem. 32: 142-145.
4. Sammalkorpi, K., V. Valtonen, Y. Kerttula, E. Nikkila, and M. R. Taskinen. 1988. Changes in serum lipoprotein pattern induced by acute infections. Metabolism. 37: 859-865.
5. de Luis, D. A., M. Lahera, R. Canton, D. Boixeda, A. L. San Roman, R. Aller, and H. de la Calle. 1998. Association of Helicobacter pylori infection with cardiovascular and cerebrovascular disease in diabetic patients. Diabetes Care. 21: 1129-1132.
6. Memon, R. A., R. Hussain, J. G. Raynes, A. Lateff, and T. J. Chiang. 1996. Alterations in serum lipids in lepromatous leprosy patients with and without ENL reactions and their relationship to acute phase proteins. Int. J. Lepr. Other Mycobact. Dis. 64: 115-122.
7. Fahie-Wilson, M., R. Mills, and K. Wilson. 1987. HDL cholesterol and the acute phase reaction following myocardial infarction and acute pancreatitis. Clin. Chim. Acta. 167: 197-209.
8. Bienvenu, J., P. Deshaires, H. Bernon, P. Armanet, P. Peristeris, A. Lepape, and J. P. Perdrix. 1988. Proteine serique amyloide A (SAA) et HDL. Implication clinique en reanimation chirurgicale. Ann. Biol. Clin. 46: 343-346.
9. Bentz, M. H., and J. Magnette. 1998. Hypocholesterolemia during the acute phase of an inflammatory reaction of infectious origin. Rev. Med. Interne. 19: 168-172.
10. Cabana, V. G., A. A. Gidding, G. S. Getz, J. Chapman, and S. T. Shulman. 1997. Serum amyloid A and high density lipoprotein participate in the acute phase response of Kawasaki disease. Ped. Res. 42: 651-655.
11. Chiang, A. N., B. Hwang, C. C. Shaw, B. C. Lee, J. H. Lu, C. C. Meng, and P. Chou. 1997. Changes in plasma levels of lipids and lipoprotein composition in patients with Kawasaki disease. Clin. Chim. Acta. 260: 15-26.
12. Kim, H., H. Yamaguchi, K. Inamo, T. Okada, and K. Harada. 1995. Changes in apolipoproteins during the acute phase of Kawasaki disease. Acta Paediat. Japon. 37: 672-676.
13. Blackman, J. D., V. G. Cabana, and T. Mazzone. 1993. The acute phase response and associated lipoprotein abnormalities accompanying lymphoma. J. Intern. Med. 233: 201-204.
14. Hachem, H., G. Favre, and G. Soula. 1988. Evidence for qualitative abnormalities in high-density lipoproteins from myeloma patients: the presence of serum amyloid A protein could explain HDL abnormalities. Biochim. Biophys. Acta. 963: 271-277.
15. Jacobs, D. R., B. Hebert, P. J. Schreiner, S. Sidney, C. Iribarren, and S. Hulley. 1997. Reduced cholesterol is associated with recent minor illness. The CARDIA study. Am. J. Epidemiol. 146: 558-564.
16. Gordon, B. R., T. S. Parker, D. M. Levine, S. D. Saal, J. C. L. Wang, B. H. Sloan, P. S. Parie, and A. L. Rubin. 1996. Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia. Crit. Care Med. 24: 584-589.
17. Cabana, V. G., J. R. Lukens, K. S. Rice, T. J. Hawkins, and G. S. Getz. 1996. HDL content and composition in APR in three species: triglyceride enrichment of HDL a factor in its decrease. J. Lipid Res. 37: 2662-2674.
18. Parks, J. S., and L. L. Rudel. 1985. Alteration of high density lipoprotein subfraction distribution with induction of serum amyloid A protein (SAA) in the non-human primate. J. Lipid Res. 26: 82-91.
19. Cabana, V. G., J. N. Siegel, and S. M. Sabesin. 1989. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. J. Lipid Res. 30: 39-49.
20. Vega, G. L., and S. M. Grundy. 1996. Hypoalphalipoproteinemia (low high density lipoprotein) as a risk factor for coronary heart disease. [Review]. Curr. Opin. Lipidol. 7: 209-216.
21. Betts, J. C., M. R. Edbrooke, R. V. Thakker, and P. Woo. 1991. The human acute-phase serum amyloid A gene family: structure, evolution and expression in hepatoma cells. Scand. J. Immunol. 34: 471-482.
22. Pepys, M. B., and M. L. Baltz. 1983. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv. Immunol. 34: 141-212.
23. Urieli-Shoval, S., R. L. Meek, R. H. Hanson, N. Eriksen, and E. P. Benditt. 1994. Human serum amyloid A genes are expressed in monocyte/macrophage cell lines. Am. J. Pathol. 145: 650-660.
24. Ramadori, G., D. Sipe, and H. R. Colten. 1985. Expression and regulation of murine serum amyloid A (SAA) gene in extrahepatic sites. J. Immunol. 135: 3645-3647.
25. Benditt, E. P., and R. L. Meek. 1989. Expression of the third member of the serum amyloid A gene family in mouse adipocytes. J. Exp. Med. 169: 1841-1846.
26. Meek, R. L., N. Eriksen, and E. P. Benditt. 1992. Murine serum amyloid A3 is a high density apolipoprotein and is secreted by macrophages. Proc. Natl. Acad. Sci. USA. 89: 7949-7952.
27. Liuzzo, G., L. M. Biasucci, J. R. Gallimore, R. L. Grillo, A. G. Rebuzzi, M. B. Pepys, and M. D. Maseri. 1994. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N. Engl. J. Med. 331: 417-424.
28. Casl, M. T., B. Surina, I. Glojnaric-Spasic, E. Pape, N. Jagarinec, and S. Kranjcevic. 1995. Serum amyloid A protein in patients with myocardial infarction. Ann. Clin. Biochem. 32: 196-200.
29. Ridker, P. M., N. Rifai, M. A. Pfeffer, F. M. Sacks, L. A. Moye, S. Goldman, G. C. Flaker, and E. Braunwald. 1998. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) investigators. Circulation. 98: 839-844.
30. Blum, A., G. Kaplan, N. Vardinon, I. Yust, M. Burke, S. Laniado, and H. Miller. 1998. Serum amyloid type A may be a predictor of restenosis. Clin. Cardiol. 21: 655-658.
31. Van Lenten, B. J., S. Y. Hama, F. C. de Beer, D. M. Stafforini, T. M. McIntyre, S. M. Prescott, B. N. La Du, A. M. Fogelman, and M. Navab. 1995. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. J. Clin. Invest. 96: 2758-2767.
32. Liang, J-s., and J. D. Sipe. 1995. Recombinant human serum amyloid A (apoSAAp) binds cholesterol and modulates cholesterol flux. J. Lipid Res. 36: 37-47.
33. Banka, C. L., T. Yuan, M. C. de Beer, M. Kindy, L. K. Curtiss, and F. C. de Beer. 1995. Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux. J. Lipid Res. 36: 1058-1065.
34. Meek, R. L., S. Urieli-Shoval, and E. P. Benditt. 1994. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc. Natl. Acad. Sci. USA. 91: 3186-3190.
35. Yamada, T., T. Kakihara, T. Kamishima, T. Fukuda, and T. Kawai. 1996. Both acute phase and constitutive serum amyloid A are present in atherosclerotic lesions. Pathol. Int. 46: 797-800.
36. Badolato, R., J. M. Wang, W. J. Murphy, A. R. Lloyd, D. F. Michiel, L. L. Bausserman, D. J. Kelvin, and J. J. Oppenheim. 1994. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J. Exp. Med. 180: 203-209.
37. Coetzee, G. A., A. F. Strachan, D. R. van der Westhuyzen, H. Hoppe, M. S. Jeenah, and F. C. de Beer. 1986. Senim amyloid A-containing human high density lipoprotein 3. J. Biol. Chem. 261: 9644-9651.
38. Williamson, R., D. Lee, J. Hagaman, and N. Maeda. 1992. Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I. Proc. Natl. Acad. Sci. USA. 89: 7134-7138.
39. Schumaker, V. N., and D. L. Puppione. 1986. Sequential flotation ultracentrifugation. Methods Enzymol. 128: 155-170.
40. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
41. Markwell, M. A., S. M. Hass, L. L. Beiber, and N. E. Tolbert. 1978. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87: 206-210.
42. Albers, J. J., P. W. Wahl, V. G. Cabana, and W. R. Hazard. 1975. Quantitation of human plasma high density lipoprotein: relationship to age, sex and lipid levels. Metabolism. 24: 633-644.
43. Weber, K., and M. Osborne. 1969. The reliability of molecular weight determination by dodecyl sulfate-polyacrylamide gel electrophoresis. J. Biol. Chem. 244: 4406-4412.
44. Blanche, P., E. Gong, T. Forte, and A. Nichols. 1981. Characterization of human high density lipoproteins by gradient gel electrophoresis. Biochim. Biophys. Acta. 665: 408-419.
45. Kashyap, M. L., B. A. Hynd, K. Robinson, and P. S. Gartside. 1981. Abnormal preponderance of sialylated apolipoprotein C-III in triglyceride-rich lipoproteins in type V hyperlipoproteinemia. Metabolism. 30: 111-118.
46. Nomenclature Committee of the International Society of Amyloidosis. J. Sipe, Subcommittee Chairperson. 1999. Int. J. Exp. Clin. Invest. In press.
47. Chirgwin, J., A. Przybyla, R. Mac Donald, and W. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry. 18: 5294-5299.
48. Pharmacia Biotech, Inc. 1977. GST Gene Fusion System, 3rd Edition, Revision 1.
49. Towbin, H., and J. Gordon. 1984. Immunoblotting and dot blotting - current status and outlook. J. Immunol. Methods. 7: 313-340.
50. Kushwaha, R. S., P. H. Barrett, C. A. Reardon, D. S. Lewis, K. D. Carey, G. S. Getz, and H. C. McGill, Jr. 1995. Relationships of plasma and hepatic variables with rates of plasma low-density lipoprotein apolipoprotein B metabolism in baboons fed low-and high-fat diets. Metabolism. 44: 1058-1066.
51. Hajri, T., R. Elliott-Bryant, J. D. Sipe, J. S. Liang, K. C. Hayes, and E. S. Cathcart. 1998. The acute phase response in apolipoprotein A-I knockout mice: apolipoprotein serum amyloid A and lipid distribution in plasma high density lipoproteins. Biochim. Biophys. Acta. 1394: 209-218.
52. Feingold, K. R., I. Hardardottir, and C. Grunfeld. 1998. Beneficial effects of cytokine induced hyperlipidemia (Review). J. Ernahrung. 37 (Suppl 1): 66-74.
53. Webb, N. R., M. C. de Beer, D. R. van der Westhuyzen, M. S. Kindy, C. L. Banka, K. Tsukamoto, D. L. Rader, and F. C. de Beer. 1997. Adenoviral vector-mediated overexpression of serum amyloid A in apoA-I-deficient mice. J. Lipid Res. 38: 1583-1590.
54. de Beer, M. C., F. C. de Beer, W. D. McCubbin, C. M. Kay, and M. S. Kindy. 1993. Structural prerequisites for serum amyloid A fibril formation. J. Biol. Chem. 268: 20606-20612.
55. Turnell, W., R. Sarra, I. D. Glover, J. Baum, D. Capsi, M. L. Baltz, and M. B. Pepys. 1986. Secondary structure prediction of human SAA1. Presumptive identification of calcium and lipid binding sites. Mol. Biol. Med. 3: 387-407.
56. Patel, H., J. Bramall, H. Waters, M. C. de Beer, and P. Woo. 1996. Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis. Biochem. J. 318: 1041-1049.